OCUGEN, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
OCUGEN, INC. (OCGN) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.08 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.08M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.38M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.30M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.58M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $1.08M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.38M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $1.30M 10-K · filed 2026-03-04 |
| 2025-09-30 | $1.58M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.55M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $1.17M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $1.37M 10-K · filed 2025-03-05 |
| 2024-09-30 | $1.46M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.55M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.67M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.69M 10-K · filed 2024-04-16 |
| 2023-09-30 | $733.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $793.00K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $856.00K 10-Q · filed 2023-05-05 |
| 2022-12-31 | $921.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $988.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.05M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $194.00K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $231.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $226.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $243.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $261.00K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $76.06K 10-K · filed 2021-03-19 |
| 2020-09-30 | $12.77K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $17.26K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $22.67K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $28.64K 10-K · filed 2020-03-27 |
| 2019-09-30 | $51.51K 10-Q · filed 2019-11-12 |
| 2019-03-31 | $2.36M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |